retatrutide make you cold Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Feeling cold on retatrutide: causes

Stress management is not a luxury during GLP-1 therapy

While there is limited evidence regarding tirzepatide use specifically in patients with significant thyroid disease (as these patients were typically excluded from pivotal trials), there is no established direct pharmacological interaction between tirzepatide and Graves disease pathophysiology

Understanding why plateaus happen and having a toolkit to overcome them is what separates successful long-term care from short-term weight loss

These drugs target metabolic pathways involving glucose regulation and appetite control, not the hormonal and inflammatory mechanisms underlying endometriosis

Timing: Some users find that timing injections relative to meals or taking them at specific times of day affects their symptom experience

Let's dive into why GLP-1 medications are changing everything for women with PCOS, and why the way they're prescribed matters just as much as the medication itself